emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университетemcardio-228Research ArticleОригинальные научные публикацииOriginal Scientific ResearchРоль эндотелиальной дисфункции и окислительного стресса в формировании сердечно-сосудистой коморбидности у больных хронической бронхолегочной патологиейThe role of endothelial dysfunction and oxidative stress in the formation of cardiovascular comorbidity in patients with chronic obstructive pulmonary diseaseГригорьеваН. Ю.GrigoryevaN. Yu.МайороваМ. В.MayorovaM. V.СамолюкМ. О.SamolukM. O.ИлюшинаТ. П.IlyushinaT. P.Приволжский исследовательский медицинский университетPrivolzhsky Research Medical UniversityГБУЗ НО «Городская клиническая больница №5»City Clinical Hospital No. 520191111202532683–688Copyright © Григорьева Н.Ю., Майорова М.В., Самолюк М.О., Илюшина Т.П., 20252025Григорьева Н.Ю., Майорова М.В., Самолюк М.О., Илюшина Т.П.Grigoryeva N.Y., Mayorova M.V., Samoluk M.O., Ilyushina T.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/228

Целью настоящего исследования явилась оценка окислительного стресса и эндотелиальной дисфункции у больных хронической обструктивной болезнью легких (ХОБЛ), имеющих сопутствующую сердечно-сосудистую патологию

The purpose of this study was to evaluate oxidative stress and endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) who had concomitant cardiovascular pathology.

коморбидностьишемическая болезнь сердцаартериальная гипертензияхроническая обструктивная болезнь легкихдисфункция эндотелияокислительный стресссomorbiditycoronary heart diseasearterial hypertensionchronic obstructive pulmonary diseaseendothelial dysfunction oxidative stressReferencesCapone C., Faraco G., Coleman C., Young C.N., Pickel V.M., Anrather J., Davisson R.L., Iadecola C. Endothelin-1-dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension, 2012, vol. 60, no. 1, рр. 106-13. DOI: 10.1161/HYPERTENSIONAHA.112.193672.Capone C., Faraco G., Coleman C., Young C.N., Pickel V.M., Anrather J., Davisson R.L., Iadecola C. Endothelin-1-dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension, 2012, vol. 60, no. 1, рр. 106-13. DOI: 10.1161/HYPERTENSIONAHA.112.193672.Cavaillès A., Brinchault-Rabin G., Dixmier A., Goupil F., Gut-Gobert C., Marchand-Adam S., Meurice J.-C. Morel H., Person-Tacnet C., Leroyer C., Diot P. Comorbidities of COPD. European Respiratory Review, 2013, vol. 22, pp. 454 –475. DOI: 10.1183/09059180.000086.Cavaillès A., Brinchault-Rabin G., Dixmier A., Goupil F., Gut-Gobert C., Marchand-Adam S., Meurice J.-C. Morel H., Person-Tacnet C., Leroyer C., Diot P. Comorbidities of COPD. European Respiratory Review, 2013, vol. 22, pp. 454 –475. DOI: 10.1183/09059180.000086.Smetneva N.S., Vikent’ev V.V., Zav’yalova S.A., Popkova A.M., Maly’shev I.Y. Rol’ vospalitel’nykh faktorov v razvitii serdechno-sosudistoj patologii pri khronicheskoj obstruktivnoj bolezni legkikh [ The role of inflammatory factors in the development of cardiovascular disease in chronic obstructive pulmonary disease]. Fundamental’nye issledovaniya, 2013, vol. 3, no. 1, рр. 162–165. (In Russian)Smetneva N.S., Vikent’ev V.V., Zav’yalova S.A., Popkova A.M., Maly’shev I.Y. Rol’ vospalitel’nykh faktorov v razvitii serdechno-sosudistoj patologii pri khronicheskoj obstruktivnoj bolezni legkikh [ The role of inflammatory factors in the development of cardiovascular disease in chronic obstructive pulmonary disease]. Fundamental’nye issledovaniya, 2013, vol. 3, no. 1, рр. 162–165. (In Russian)Ives S.J, Harris R.A, Witman M.A. Fjeldstad A.S., Garten R.S., McDaniel J., Wray D.W., Richardson R.S. Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension, 2014, vol. 63, no. 3, pp. 459–467. DOI: 10.1161/HYPERTENSIONAHA.113.02255.Ives S.J, Harris R.A, Witman M.A. Fjeldstad A.S., Garten R.S., McDaniel J., Wray D.W., Richardson R.S. Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension, 2014, vol. 63, no. 3, pp. 459–467. DOI: 10.1161/HYPERTENSIONAHA.113.02255.Rahman T., Hosen I., Towhidul Islam M.M., Shekhar H. U. Oxidative stress and human health, Advances in Bioscience and Biotechnology. Hossain Uddin Shekhar, 2012, vol. 3, no. 7, pp. 997-1019. DOI: 10.4236/ abb. 2012. 327123.Rahman T., Hosen I., Towhidul Islam M.M., Shekhar H. U. Oxidative stress and human health, Advances in Bioscience and Biotechnology. Hossain Uddin Shekhar, 2012, vol. 3, no. 7, pp. 997-1019. DOI: 10.4236/ abb. 2012. 327123.Park K.H., Park W.J. Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches. J Korean Med Sci, 2015, vol. 30, no. 9, pp. 1213–1225. DOI: 10.3346/jkms.2015.30.9.1213.Park K.H., Park W.J. Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches. J Korean Med Sci, 2015, vol. 30, no. 9, pp. 1213–1225. DOI: 10.3346/jkms.2015.30.9.1213.Mordi I., Mordi N., Delles C., Tzemos N. Endothelial dysfunction in human essential hypertension. J Hypertension, 2016, vol. 34, no. 8, pp. 1464–1472. DOI:10.1097/HJH.0000000000000965.Mordi I., Mordi N., Delles C., Tzemos N. Endothelial dysfunction in human essential hypertension. J Hypertension, 2016, vol. 34, no. 8, pp. 1464–1472. DOI:10.1097/HJH.0000000000000965.Atsou K., Chouaid C., Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med, 2011, vol. 9, pp. 7. DOI: 10.1186/1741-7015-9-7.Atsou K., Chouaid C., Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med, 2011, vol. 9, pp. 7. DOI: 10.1186/1741-7015-9-7.Singh D., Agusti A., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Criner G.J., Frith P., Halpin D.M.G., Han M., López Varela M.V., Martinez F., Montes de Oca M., Papi A., Pavord I.D., Roche N., Sin D.D., Stockley R., Vestbo J., Wedzicha J.A., Vogelmeier C. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J, 2019, vol. 53, no. 5, pii: 1900164. DOI: 10.1183/13993003.00164-2019.Singh D., Agusti A., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Criner G.J., Frith P., Halpin D.M.G., Han M., López Varela M.V., Martinez F., Montes de Oca M., Papi A., Pavord I.D., Roche N., Sin D.D., Stockley R., Vestbo J., Wedzicha J.A., Vogelmeier C. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J, 2019, vol. 53, no. 5, pii: 1900164. DOI: 10.1183/13993003.00164-2019.Zykov K.А., Sokolov E.I. Novaya klassifikatsiya khronicheskoj obstruktiv-noj bolezni legkikh: novye vozmozhnosti ili novye problemy? [New classification of chronic obstructive pulmonary disease: new opportunities or new challenges] Consilium Medicum, 2013, vol. 15, no. 5, pp. 42–47. (In Russian).Zykov K.А., Sokolov E.I. Novaya klassifikatsiya khronicheskoj obstruktiv-noj bolezni legkikh: novye vozmozhnosti ili novye problemy? [New classification of chronic obstructive pulmonary disease: new opportunities or new challenges] Consilium Medicum, 2013, vol. 15, no. 5, pp. 42–47. (In Russian).Starodubov V.I., Leonov S.А., Vajsman D.SH. Аnaliz osnovnykh tendentsij izmeneniya zabolevaemosti naseleniya khronicheskimi obstruktivnymi boleznyami legkikh i bronkhoehktaticheskoj bolezn’yu v Rossijskoj Federatsii v 2005-2012 godakh. [Analysis of the main trends in the incidence of chronic obstructive pulmonary disease and bronchiectatic disease in the Russian Federation in 2005-2012]. Meditsina, 2013, vol. 1, no. 4, pp. 1–31. (In Russian).Starodubov V.I., Leonov S.А., Vajsman D.SH. Аnaliz osnovnykh tendentsij izmeneniya zabolevaemosti naseleniya khronicheskimi obstruktivnymi boleznyami legkikh i bronkhoehktaticheskoj bolezn’yu v Rossijskoj Federatsii v 2005-2012 godakh. [Analysis of the main trends in the incidence of chronic obstructive pulmonary disease and bronchiectatic disease in the Russian Federation in 2005-2012]. Meditsina, 2013, vol. 1, no. 4, pp. 1–31. (In Russian).Leshhenko I.V., Baranova I.I. Biomarkery vospaleniya pri khronicheskoj obstruktivnoj bolezni legkikh [Biomarkers of inflammation of chronic obstructive pulmonary disease]. Pul’monologiya, 2012, no. 2, рр. 108–117. (In Russian)Leshhenko I.V., Baranova I.I. Biomarkery vospaleniya pri khronicheskoj obstruktivnoj bolezni legkikh [Biomarkers of inflammation of chronic obstructive pulmonary disease]. Pul’monologiya, 2012, no. 2, рр. 108–117. (In Russian)Almagro P., Cabrera F.J., Diez J., Boixeda R., Recio J., Mercade J., Yun S., Soriano J.B. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the ESMI study. Eur Res J, 2015, vol. 46, no. 5, pp. 850–853.Almagro P., Cabrera F.J., Diez J., Boixeda R., Recio J., Mercade J., Yun S., Soriano J.B. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the ESMI study. Eur Res J, 2015, vol. 46, no. 5, pp. 850–853.Anderson W., Lipworth B., Rekhraj S., Struthers A.D., George J. Left Ventricular Hypertrophy in Chronic Obstructive Pulmonary Disease without Hypoxaemia: The Elephant in the Room? Chest, 2013, vol. 143, no. 1, pp. 91–97. DOI: 10.1378/ chest.12-0775.Anderson W., Lipworth B., Rekhraj S., Struthers A.D., George J. Left Ventricular Hypertrophy in Chronic Obstructive Pulmonary Disease without Hypoxaemia: The Elephant in the Room? Chest, 2013, vol. 143, no. 1, pp. 91–97. DOI: 10.1378/ chest.12-0775.Gkaliagkousi E., Gavriilaki E., Triantafyllou A., Douma S. Clinical Significance of Endothelial Dysfunction in Essential Hypertension. Curr Hypertens Rep, 2015, vol. 17, no. 11, pp. 85. DOI: 10.1007/s11906-015-0596-3.Gkaliagkousi E., Gavriilaki E., Triantafyllou A., Douma S. Clinical Significance of Endothelial Dysfunction in Essential Hypertension. Curr Hypertens Rep, 2015, vol. 17, no. 11, pp. 85. DOI: 10.1007/s11906-015-0596-3.Vertkin А.L., Skotnikov А.S., Gubzhokova O.M. Komorbidnost’ pri khronicheskoj obstruktivnoj bolezni legkikh: rol’ khronicheskogo sistemnogo vospaleniya i kliniko-farmakologicheskie nishi roflumilasta [Comorbidity in chronic obstructive pulmonary disease: the role of chronic systemic inflammation and clinical and pharmacological niches of roflumilast]. Lechashhij vrach, 2013, no. 11, pp. 85–88. (In Russian).Vertkin А.L., Skotnikov А.S., Gubzhokova O.M. Komorbidnost’ pri khronicheskoj obstruktivnoj bolezni legkikh: rol’ khronicheskogo sistemnogo vospaleniya i kliniko-farmakologicheskie nishi roflumilasta [Comorbidity in chronic obstructive pulmonary disease: the role of chronic systemic inflammation and clinical and pharmacological niches of roflumilast]. Lechashhij vrach, 2013, no. 11, pp. 85–88. (In Russian).Li V.V., Zadionchenko V.S., Adasheva T.V., Pavlov S.V., Malinicheva Yu.V., Samorukova E.I., Salmanova E.A., Lugovcova J.V. Аrterial’naya gipertoniya u bol’nykh khronicheskoj obstruktivnoj bolezn’yu legkikh – v poiskakh fenotipov. CHast’ 1 [Arterial hypertension and patients with chronic obstructive pulmonary disease-in search of phenotypes. Part 1]. Аrkhiv vnutrennij meditsiny, 2013, no. 1, no. 9, pp. 19–24. (In Russian).Li V.V., Zadionchenko V.S., Adasheva T.V., Pavlov S.V., Malinicheva Yu.V., Samorukova E.I., Salmanova E.A., Lugovcova J.V. Аrterial’naya gipertoniya u bol’nykh khronicheskoj obstruktivnoj bolezn’yu legkikh – v poiskakh fenotipov. CHast’ 1 [Arterial hypertension and patients with chronic obstructive pulmonary disease-in search of phenotypes. Part 1]. Аrkhiv vnutrennij meditsiny, 2013, no. 1, no. 9, pp. 19–24. (In Russian).Münzel T., Camici G.G., Maack C., Bonetti N.R., Fuster V., Kovacic J.C. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-Part series. J Am Cardiol, 2017, vol. 70, no. 2, pp. 212–229. DOI: 10.1016/j.jacc.2017.05.035.Münzel T., Camici G.G., Maack C., Bonetti N.R., Fuster V., Kovacic J.C. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-Part series. J Am Cardiol, 2017, vol. 70, no. 2, pp. 212–229. DOI: 10.1016/j.jacc.2017.05.035.Leurgans T.M., Bloksgaard M., Irmukhamedov A., Riber L.P., De Mey J.G.R. Relaxing responses to hydrogen peroxide and nitric oxide in human pericardial resistance arteries stimulated with endothelin-1. Basic & clinical pharmacology & toxicology, 2018, vol. 122, no. 1, рр. 74–81. DOI: 10.1111/bcpt.12843.Leurgans T.M., Bloksgaard M., Irmukhamedov A., Riber L.P., De Mey J.G.R. Relaxing responses to hydrogen peroxide and nitric oxide in human pericardial resistance arteries stimulated with endothelin-1. Basic & clinical pharmacology & toxicology, 2018, vol. 122, no. 1, рр. 74–81. DOI: 10.1111/bcpt.12843.

The authors declare that there are no conflicts of interest present.